Disclosure Information Listed for CME Content Development and Approval Committee and Participating Program Faculty

In accordance with the Accreditation Council for Continuing Medical Education (ACCME), National Jewish Health requires that all program faculty, content developers, CME approval committee, and medical writers in a position to control the content of this activity are expected to disclose any or not significant financial interest or other relationship with any proprietary entity producing health care goods or services, with the exemption of non-profit or governmental organizations and non-health care related companies. Our goal is to ensure that there is no compromise of the ethical relationship that exists between those in a position to control the content of the activity and those attending the activity and their respective professional duties

Significant financial interest is defined as receiving, or in the past twelve months having received, a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected.

All CME Educational Activities sponsored by National Jewish Health are reviewed by our faculty CME committee to ensure a balanced and evidence-based presentation. Any potential conflict of interest among program faculty has been identified and resolved according to ACCME guidelines.

Faculty Disclosures

In accordance with the ACCME, National Jewish Health requires that all persons in a position to control the content of a CME activity, including the CME review committee disclose all significant financial interest with commercial interests.

KEY
A - Advisory Board    C - Consultant   I - Investigator   O - Other

Richard Casaburi, PhD, MD
COPDGene Clinical Center Director
Associate Chief, Division of Respiratory
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
C - AstraZeneca, Boehringer-Ingelheim, Forest, Merck, Novartis, Pfizer, Respironics, Roche
I - GlaxoSmithKline, Forest, Novartis, Osiris, Roche

Bartolome Celli, MD
Division of Pulmonary and Critical Care Medicine
Brigham and Women's Hospital
Harvard Medical School
A - Almirall, Boehringer-Ingelheim, GlaxoSmithKline, Pfizer
C - Aeris Therapeutics, Boehringer-Ingelheim, GlaxoSmithKline
O - Eskeve, Forest

James Crapo, MD
Professor of Medicine
University of Colorado Denver
National Jewish Health
Has no significant financial interest to report

Gerard J. Criner, MD
Professor of Medicine
Director, Pulmonary and Critical Care Medicine
Temple Lung Center
Temple University School of Medicine
A - Dey, L.P.
I - Boehringer-Ingelheim, GlaxoSmithKline, Schering-Plough

James P. Kiley, PhD, MS
Director, Division of Lung Diseases
National Heart, Lung, and Blood Institute
National Institutes of Health
Has no significant financial interest to report

Nicola A. Hanania, MD, MS
Associate Professor of Medicine Section of Pulmonary and Critical Care Medicine
Baylor College of Medicine, Houston, Texas
C - GlaxoSmithKline, Nycomed
I - Boehringer-Ingelheim, Dey, GlaxoSmithKline, Novartis, Nycomed, Pfizer, Sepracor
SP - AstraZeneca, GlaxoSmithKline

Harold S. Nelson, MD
Professor of Medicine
National Jewish Health
C - Abbott, AstraZeneca, Boehringer-Ingelheim, Dey, L.P., Dynavax Technologies, Dyson, Genentech, GlaxoSmithKline, Johnson & Johnson, MediciNova, Novartis, Schering- Plough, Sepracor, Teva
I - Altana, AstraZeneca, Boehringer-Ingelheim, Ception, Genentech, Novartis, Schering-Plough, Sepracor, Wyeth
SP - AstraZeneca, GlaxoSmithKline

Elizabeth Regan, MD, PhD
Assistant Professor
University of Colorado Denver
Associate Director, COPD Gene
National Jewish Health
Has no significant financial interest to report

Debra Gordon, MS
Medical Writer
Has no significant financial interest to report.

This activity is sponsored by National Jewish Health.

Commercial Support

This educational activity was made possible by an educational grant from Pfizer.